| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2008 | CA2660086A1 Method of making solid dispersions of highly crystalline therapeutic compounds |
| 02/21/2008 | CA2659562A1 Stable lyophilized preparation |
| 02/21/2008 | CA2659257A1 Organic nanoparticles and method of preparation thereof |
| 02/21/2008 | CA2633112A1 A method of treating tumors with azaxanthones |
| 02/20/2008 | EP1889841A1 Crystal of salt of benzimidazole compound |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889629A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 02/20/2008 | EP1889628A1 Lipid liposome composition |
| 02/20/2008 | EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 02/20/2008 | EP1889621A1 Multiparticulates |
| 02/20/2008 | EP1889620A1 Eye drop containing roflumilast |
| 02/20/2008 | EP1889611A1 Sugar-coated tablet |
| 02/20/2008 | EP1889610A2 Bicalutamide compositions |
| 02/20/2008 | EP1889609A2 Immune response modifier foam formulations |
| 02/20/2008 | EP1889608A1 Therapeutic hydrogel for atopic dermatitis and preparation method thereof |
| 02/20/2008 | EP1889607A1 Injectable liquid paracetamol formulation |
| 02/20/2008 | EP1889594A2 Aqueous cataplasms containing watercress extract |
| 02/20/2008 | EP1889198A2 Pharma-informatics system |
| 02/20/2008 | EP1888676A2 Method for producing a composite material comprising active substance solid dispersions in a polymer matrix |
| 02/20/2008 | EP1888624A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 02/20/2008 | EP1888510A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/20/2008 | EP1888223A2 Method and device for encapsulating materials in liposomes comprising a freely adaptable membrane structure |
| 02/20/2008 | EP1888126A1 Method for terminal sterilization of transdermal delivery devices |
| 02/20/2008 | EP1888124A1 Mri contrast medium containing liposomes |
| 02/20/2008 | EP1888117A1 Stabilized polypeptide formulations |
| 02/20/2008 | EP1888107A2 Novel vaccine formulations |
| 02/20/2008 | EP1888088A1 Bacterial management in animal holding systems |
| 02/20/2008 | EP1888080A1 Pharmaceutical compositions of a neuroactive steroid and usees thereof |
| 02/20/2008 | EP1888075A1 Therapeutic combination in case of benign prostate hyperplasia |
| 02/20/2008 | EP1888073A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888072A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl]and salts thereof |
| 02/20/2008 | EP1888048A2 Method for handling adhesive laminate sections |
| 02/20/2008 | EP1888047A2 Oral ribavirin pharmaceutical compositions |
| 02/20/2008 | EP1888046A2 Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles |
| 02/20/2008 | EP1888045A2 Oral pharmaceutical composition for treating a cox-2 mediated condition |
| 02/20/2008 | EP1888044A1 Dried formulations of nanoparticle-coated capsules |
| 02/20/2008 | EP1888043A2 Controlled release formulations of octreotide |
| 02/20/2008 | EP1888042A2 Flavoring of drug-containing chewing gums |
| 02/20/2008 | EP1888041A2 Implantable pump with infinitely variable resistor |
| 02/20/2008 | EP1888040A2 Pharmaceutical compositions comprising imatinib and a release retardant |
| 02/20/2008 | EP1888039A2 Dustless powder materials |
| 02/20/2008 | EP1888038A2 Modified release famciclovir pharmaceutical compositions |
| 02/20/2008 | EP1888037A2 Nanoparticulate clopidogrel formulations |
| 02/20/2008 | EP1888036A1 Compositions for drug delivery |
| 02/20/2008 | EP1888035A2 Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents |
| 02/20/2008 | EP1888034A2 Compositions and methods using same for delivering agents into a target organ protected by a blood barrier |
| 02/20/2008 | EP1888033A2 Method and composition for treating inflammatory disorders |
| 02/20/2008 | EP1888032A2 Saccharide foamable compositions |
| 02/20/2008 | EP1888031A1 Glp-1 analogue formulations |
| 02/20/2008 | EP1888030A1 Pediatric formulation of topiramate |
| 02/20/2008 | EP1888029A2 Topical ungual formulations |
| 02/20/2008 | EP1888028A1 Pharmaceutical dosage form effective at microcirculatory level containing at least one flavanoid |
| 02/20/2008 | EP1888027A1 Medicated product for local use based on natural materials |
| 02/20/2008 | EP1888026A2 A stable liquid formulation comprising desoximetasone and isopropyl myristate with reduced oxidized impurity during long-term storage |
| 02/20/2008 | EP1888025A2 Medicament carrier composition and method of forming a film therefrom |
| 02/20/2008 | EP1888024A1 Topical compositions |
| 02/20/2008 | EP1888013A1 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof |
| 02/20/2008 | EP1888001A2 Patch for transdermal drug delivery |
| 02/20/2008 | EP1887866A1 Spot-on formulations for combating parasites |
| 02/20/2008 | EP1887864A1 Method and composition for use in preparation of a patient for surgery |
| 02/20/2008 | EP1753440B1 Oral form of administration containing probiotic bacteria |
| 02/20/2008 | EP1694299B1 Method for drug loading in liposomes |
| 02/20/2008 | EP1603559B1 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
| 02/20/2008 | EP1589992A4 Method for treating elevated intraocular pressure, including glaucoma |
| 02/20/2008 | EP1575600B1 Cosmetic preparations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride |
| 02/20/2008 | EP1575550B1 Use of biologically inhibiting material for inhibiting live cells |
| 02/20/2008 | EP1555022B1 Sustained release formulation of acetaminophen and tramadol |
| 02/20/2008 | EP1539108B1 Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 02/20/2008 | EP1458389B1 Aqueous solutions of moxaverin for the treatment of erectile dysfunction |
| 02/20/2008 | EP1455832B1 Pulsed bio-agent delivery systems based on in vivo degradable and swellable modified dextran hydrogels |
| 02/20/2008 | EP1451242B1 Water-in-silicone emulsions |
| 02/20/2008 | EP1446176B1 Microneedle transdermal transport device |
| 02/20/2008 | EP1443964B1 Photodynamic therapy for the treatment of hair loss |
| 02/20/2008 | EP1427392B1 New self emulsifying drug delivery system |
| 02/20/2008 | EP1414407B1 Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane |
| 02/20/2008 | EP1372637B1 Premixed amiodarone parenteral solution and method for making the same |
| 02/20/2008 | EP1333846A4 Preparation and xenotransplantation or porcine islets |
| 02/20/2008 | EP1330276B1 Implantable medical device for delivering a liquid |
| 02/20/2008 | EP1194170B1 Growth hormone formulations |
| 02/20/2008 | EP1171124B1 Anthelmintic compositions |
| 02/20/2008 | EP1154761B1 Solid oral dosage form containing an enhancer |
| 02/20/2008 | EP1101497B1 Stabilized oily preparations of tobicillin (beta-lactam antibiotic) |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP1029537B1 Sustained release eyedrops |
| 02/20/2008 | EP0986309B1 Uses of oil bodies |
| 02/20/2008 | EP0855906B1 Insoluble drug delivery |
| 02/20/2008 | CN201022856Y Medicine plaster for treating bone pains of numbness |
| 02/20/2008 | CN201022855Y External-applied powder agent soluble plaster |
| 02/20/2008 | CN201022854Y Double rings medicine plaster |
| 02/20/2008 | CN101128515A Polyoxyalkylene-alkyl functional siloxane resins and aqueous compositions thereof |
| 02/20/2008 | CN101128233A Medicament delivery device comprising a flexible edible bag |
| 02/20/2008 | CN101128206A Tetracycline metal complex in a solid dosage form |
| 02/20/2008 | CN101128205A Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release |
| 02/20/2008 | CN101128203A Composition comprising ocaperidone |
| 02/20/2008 | CN101128191A Dosage form containing oxycodone and naloxone |
| 02/20/2008 | CN101128190A Controlled-release formulation containing tamsulosin hydrochloride |
| 02/20/2008 | CN101128189A Tablets with improved drug substance dispersibility |
| 02/20/2008 | CN101128188A Formulations of substituted benzoxazoles |
| 02/20/2008 | CN101128187A Colonic delivery of active agents |
| 02/20/2008 | CN101128186A Fast wet-massing method for the preparation of calcium-containing compositions |